Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia

Annals of Thoracic Medicine

Volumn 10, Issue 2, 2015, Pages 137-142

  Tanriverdi, Hakan ^a   Tor, Müge Meltem ^a   Kart, Levent ^b   Altin, Remzi ^c   Atalay, Figen ^a   Sumbsümbüloglu, Vildan ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^c NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Intensive care unit; pneumonia; procalcitonin; prognosis

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACINETOBACTER; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ESCHERICHIA COLI; FEMALE; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84924766462     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.151442     Document Type: Article

References (25)

1. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997;46:1-79
2. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilatorassociated pneumonia. Chest 1993;104:1230-5
3. Rello J, Ausina V, Castella J, Net A, Prats G. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992;102:525-9
4. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
5. Simsek S, Yurtseven N, Gercekoglu H, Izgi H, Sohtorik U, Canik S., et al. Ventilator associated pneumonias in a cardiothoracic surgery centre postoperative intensive care unit. J Hosp Infect 2001;47:321-4
6. Seligman R, Seligman BG, Teixeira PJ. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia. J Bras Pneumol 2011;37:495-503
7. Cook DJ, Walter SD, Cook RJ, Grif?th LE, Guyatt GH, Leasa D., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40
8. Trouillet JL, Chastre J, Vuagnat A, Joly-Goillou ML, Combaux D, Dombret MC., et al. Ventilator associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9
9. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627-34
10. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M., et al. Procalcitonin kinetics as a prognostic marker of ventilatorassociated pneumonia. Am J Respir Crit Care Med 2005;171:48-53
11. Seligman R, Meisner M, Lisboa TC, Hertz FT, Flippin TB, Fachel JM., et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10:R125
12. Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein, and APACHE II scores for risk evalution in patients with severe pneumonia. Clin Microbiol Infect 2002;8:93-100
13. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3:45-50
14. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504
15. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003;31:1737-41
16. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y., et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005;11:152-9
17. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE., et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402
18. Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S., et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003;21:939-43
19. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D, Allauchiche B. Alveolar and serum procalcitonin: Diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002;96:74-9
20. Tuʇrul S, Esen F, Çelebi S, Ozcan PE, Akinci O, Cakar N., et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002;30:747-54
21. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 2013;309:717-8
22. Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM., et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008;31:356-62
23. Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Zimmerli W., et al. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community acquired pneumonia. Clin Chem Lab Med 2014
24. Zielinska-Borkowska U, Skirecki T, Zlotorowicz M, Czarnocka B. Procalcitonin in early onset ventilator-associated pneumonia. J Hosp Infect 2012;81:92-7
25. Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013;17:R115